Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Merck KGaA

Germany

CMS manufacturer 100000511815

Open in the dashboard

General payments

$1,615,271

552 payments

Research payments

$2,296,819

144 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Merck KGaA reported paying $1,615,271 in general payments and $2,296,819 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $193,175 79
2025 Research $1,350 3
2024 General $285,732 101
2024 Research $4,831 31
2023 General $166,601 62
2023 Research $616,771 90
2022 General $464,571 153
2022 Research $203,815 1
2021 General $254,575 86
2021 Research $464,753 5
2020 General $117,429 24
2020 Research $897,289 8
2019 General $133,188 47
2019 Research $108,010 6

Breakdown

Top recipients General payments · program year 2025
  1. Jeremy Sugarman Internal Medicine · Baltimore, MD $32,702 9 payments
  2. Victoria Werth Dermatology · Philadelphia, PA $17,992 5 payments
  3. Kurt Barnhart Reproductive Endocrinology · Philadelphia, PA $14,607 4 payments
  4. Amanda Hernandez-Jones Neurology · Farmington, CT $12,089 5 payments
  5. Annette Okai Neurology · Plano, TX $11,120 2 payments
  6. George Demetri Medical Oncology · Boston, MA $10,075 3 payments
  7. Neelam Goyal Neurology · Stanford, CA $10,050 7 payments
  8. William Conte Neurology · Merrillville, IN $9,768 3 payments
  9. David Duong Internal Medicine · Boston, MA $6,988 8 payments
  10. Gregory Wu Neurology · Saint Louis, MO $6,720 1 payment
Top research recipients Research payments · program year 2025
  1. Shields Radiology Associates $1,350 3 payments
Products the payments named General payments · program year 2025
  1. Erbitux Oncology $5,250 100% · 1 recipient

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $82,202 43% · 19 practitioners
  2. Internal Medicine $42,804 22% · 4 practitioners
  3. Medical Oncology Internal Medicine $18,520 10% · 3 practitioners
  4. Dermatology $17,992 9% · 1 practitioner
  5. Reproductive Endocrinology Obstetrics & Gynecology $14,607 8% · 1 practitioner

The top 5 of 10 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $35,337 18% · 3 recipients
  2. Pennsylvania $33,649 17% · 3 recipients
  3. California $21,514 11% · 6 recipients
  4. Massachusetts $20,663 11% · 4 recipients
  5. Texas $19,565 10% · 3 recipients

The top 5 of 16 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $900,569 256 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $455,275 129 payments
  3. Travel and Lodging $237,418 122 payments
  4. Royalty or License $18,000 2 payments
  5. Food and Beverage $4,010 43 payments
Companies with a similar name General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation NJ, United States $176,852,890
  2. Merck Healthcare KGaA Germany $777,396
  3. Merck, S.L.U. Spain $8,086
  4. Merck Serono S.p.A. Italy $8,015

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

552 general · 144 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record